|
Published by: Espicom Healthcare Intelligence
Published: Sep. 30, 2009 - 108 Pages
Table of Contents
- EXECUTIVE SUMMARY
- Introduction
- Pharmaceutical Market Analysis
- Size
- Market Structure
- Pharmacy Sector
- Hospital Sector
- Prescribed Medicines
- Generic Medicines
- OTC Medicines
- Draft Law to Sell OTC Medicines Outside Pharmacies
- Projections & Outlook
- Drug Quality Assessment Loophole Found in 2008
- Imports
- Trade Associations
- ASILFA
- CAMEVED
- CANALAB
- CIF
- Domestic Production
- FTA Developments
- Local Manufacturers
- Andrómaco
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Exports
- International Divisions
- Bagó
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Exports
- Bestpharma
- Product Portfolio
- Biosano
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- LabChile
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Exports
- Distribution
- Labomed
- Maver
- Mintlab
- Recalcine
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Research & Development
- Sanderson
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Exports
- Saval
- Financial Indicators
- Product Portfolio
- Manufacturing Capabilities
- Exports
- Exports
- Research & Development
- Pharmaceutical Regulatory Analysis
- Pharmaceutical Regulation
- Public Consultation on New Pharmaceutical Regulations
- Pharmaceutical Registration
- Quality Standards
- Stock Control
- Legal Proceedings
- Drug Approval Process
- Advertising
- Patent Protection & Intellectual Property Rights
- Chile on 2008 ‘Priority Watch List’ for IPR
- Pricing & Reimbursement
- Reimbursement
- Pharmaceutical Distribution
- Distribution Developments in the Retail Market
- Pharmacy Own-Labelled Production
- Retail Pharmacy Chains
- Cruz Verde
- Farmacias Ahumada
- Farmacias SalcoBrand
- FarmaLider
- CENABAST
- Healthcare Analysis
- Demographics
- Population
- Birth Rate
- Death Rate
- Infant Mortality
- Life Expectancy at Birth
- Public Health
- Causes of death
- Incidence of Communicable Disease
- Incidence of Non-communicable disease
- Chileans Suffer From High Rates of Digestive Illness
- HIV/AIDS
- Healthcare System
- SNSS / FONASA
- Isapres
- Isapre Changes, Problems and Price Increases
- The Reform
- Financing Government Expenditure Law
- Health Authority & Management Law
- Health Guarantees System Law
- Private Health Law
- Rights & Duties Law
- Health Expenditure
- Health Expenditure Projections
- Healthcare Infrastructure
- Inpatient Analysis
- Healthcare Personnel
- Physician Projections
- DIRECTORY
- Government Organisations
- Trade Associations
- Methodology and Sources
- List of Tables
- Summary of Key Data Projections, 2009-2014
- Summary of the Chilean Pharmaceutical Market, 2009
- Market Value by Sector, 1993-2007 (US$ Million)
- Change in US$ Market Value by Sector, 1993-2007 (%)
- Market Value by Sector, 1993-2005 (As % of Total)
- Market Value by Sector, 1993-2002 (Billion Pesos)
- Pharmacy Sector by Value & Volume, 2006
- Pharmacy Sector by Value & Volume, 2005
- Pharmacy Sector by Value & Volume, 2004
- Pharmacy Sector Value by Leading Producers, June 2005 (Million Pesos)
- Pharmacy Sector Value by Leading Producers, June 2005 (US$ Million)
- Pharmacy Sector Value & Volume by Origin of Supplier, March 2005 (%)
- Leading Therapeutic Categories by Value & Volume, 2004 (US$ Million & Million Units) .. 9
- Leading Therapeutic Categories, 2004 (Million Units)
- Market Projections at Retail Prices, 2009-2014
- SWOT Analysis of the Chilean Pharmaceutical Market, 2009
- SWOT Analysis of the Chilean Health System, 2009
- Espicom Analysis of the Chilean Pharmaceutical Market, 2009
- Pharmaceutical Imports, 2003-2007 (US$000’s)
- Import Trends
- Leading Suppliers of Raw Materials, 2007 (US$000s)
- Leading Suppliers of Medicaments, 2007 (US$000s)
- ASILFA’s Members, 2008
- CANALAB’s Members, 2008
- CIF’s Members, 2008
- Summary of Pharmaceutical Establishments & Workforce, 2000-2005
- Pharmaceutical Establishments & Workforce by Company Size, 2000-2005
- Summary of Pharmaceutical Production, 2000-2005 (Million Pesos)
- Summary of Pharmaceutical Production, 2000-2005 (US$ Million)
- Pharmaceutical Production by Company Size, 2000-2005 (Million Pesos)
- Andrómaco’s Sales, 2000-2007 (Billion Pesos)
- Biosano’s Product Portfolio, 2008
- Pharmaceutical Producers Represented by Labomed, 2007
- Pharmaceutical Exports, 2003-2007 (US$000’s)
- Export Trends
- Leading Destinations, 2007 (US$000s)
- Leading Exporters of Pharmaceuticals, 2002-2007(US$ Million)
- Number of Product Registrations, 1999-2006
- Summary Demographic Data 2005-07
- Projected Population, 2009-2014
- Health Beneficiaries, 1990-2008
- Isapres’ Beneficiaries, 1990-2007
- Beneficiaries by Isapre Type, 2007
- Major Structural Implementations, 2000-2010
- The Five-Law Reform Bill, 2004
- Total AUGE Programme Patients, October 2007
- AUGE Pilot Programme Patients, August 2002-November 2004
- Healthcare Expenditure, 2006
- Projected Health Expenditure, 2009-14
- Hospitals and Beds, 2005-06
- Hospital Bed Projections, 2009-2014
- Projected Number of Physicians, 2009-14 (000s)
- List of Figures
- Pharmacy Sector by Value & Volume, 2005
- Pharmacy Sector by Value & Volume By Supplier’s Origin, March 2005
- Radar Graph of the Chilean Pharmaceutical Market, 2009
- Pharmaceutical Imports, 2007 (As % of Total)
- Leading Suppliers, 2007 (%)
- Pharmaceutical Production, 2000-2005
- Andromaco’s Sales, 2000-2007
- Saval’s Sales, 2003-2006
- Pharmaceutical Exports by Category, 2007 (%)
- Leading Destinations, 2007 (%)
- Leading Exporters of Pharmaceuticals, 2007 (US$ Million)
- Drug Pricing by Product Type, 2002-05 (US$)
- Pharmacy Sector by Distribution Channels, 2006 (%)
- FASA’s Sales, 2000-07 (US$)
- Healthcare Institutions’ Organisation
- Isapres’ Benificiaries, 1990-2007
- Beneficiaries by Isapre Type, 2007
AbstractEspicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.
Please note: This is delivered as a Zip file.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
